We are live on
!
Find out more
TCMG
TSP Capital Management Group Portfolio holdings
AUM
$418M
1-Year Est. Return
68.45%
This Fund
S&P 500
This Quarter
Est. Return
+5.05%
1 Year Est. Return
+68.45%
3 Year Est. Return
+177.76%
5 Year Est. Return
+247.33%
10 Year Est. Return
+1,387.97%
AUM
$230M
AUM Growth
+$9.77M
(+4.4%)
Cap. Flow
+$223M
Cap. Flow
% of AUM
96.62%
Top 10 Holdings %
Top 10 Hldgs %
40.35%
Holding
74
New
74
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celldex Therapeutics
CLDX
|
+$12.2M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$11.2M |
| 3 |
SE
Spectra Energy Corp Wi
SE
|
+$11M |
| 4 |
Comcast
CMCSA
|
+$9M |
| 5 |
Xylem
XYL
|
+$8.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.3% |
| 2 | Materials | 13.67% |
| 3 | Communication Services | 13.16% |
| 4 | Industrials | 9.45% |
| 5 | Utilities | 8.06% |
Similar funds
FFA
WPI
TI
VIS
MCM
PA
PIMC
DBRC
TSP Capital Management Group's Q2 2014 Portfolio in Review
As of Q2 2014, TSP Capital Management Group held 74 positions worth $230M, up 4.4% from $221M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
TSP Capital Management Group deployed $223M of net new capital in Q2 2014, opening 74 new positions. Its largest new stake was Celldex Therapeutics: 54,084 shares worth $13.2M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Materials and Communication Services.
- TSP Capital Management Group's largest Q2 2014 buy was Celldex Therapeutics: 54,084 shares worth $13.2M.
- TSP Capital Management Group's ten largest holdings make up 40% of its $230M portfolio in Q2 2014.
- TSP Capital Management Group opened 74 new positions and closed 0 in Q2 2014.
- TSP Capital Management Group's portfolio value rose 4.4% quarter-over-quarter to $230M.
Based on TSP Capital Management Group's 13F filing for Q2 2014, filed 1 Aug 2014.